RE: drug lords7 Nov 2019 18:08
I always find the Secker debates interesting..
Most of what is levied against him is his somewhat stuttery public demeanour, apparent lack of confidence in public speaking, and having less charisma than some of the more fragrant characters "working" (on) the AIM market. Whilst I agree with all of those, had I invested earlier in the summer in the 50/60s, or even a couple years ago in excess of a quid per share, the Company has achieved everything I would have hoped for between then and now.
Tie ups with the biggest names in the industry, proving up the monster resource at Sonora and substantial in its own right offering at Zin, and getting the right partner with the background and experience to maximize Sonora. As the face of the company he takes the flak for the company being at the lowest its ever been in the past five years during 2019, and given the progress on the above fronts, understandably so.
But, as a point of discussion, what more can he do? Any AIM CEOs that overegg expectations, often fall flat on their face in a pump and dump manner. Personally, I cannot fathom why the BOD don't buy shares (there can't be a closed period now the deal is finalised) and I think more could be done on PR. I'm not overly impressed with the social media account for example re-hashing months old articles after seeing them on a bulletin board - that doesn't constitute strong PR. Anyone else any ideas?
I'm genuinely at a loss as to why this is trading at such a paltry market cap, and cannot see a future funding gap down the line (now having partners of the ilk that BCN have) being a legitimate reason for such a depressed price.
Lithium ETF now 19% off its recent lows, and breaking out. How IIs aren't coming here and scooping us this price is genuinely defying belief for me too.